So-Young International Inc. (SY) Q1 2025: Aesthetic Centers Drive 551% Revenue Surge Amid Strategic Vertical Integration

May 16, 2025 | By EarningsIQ Research

So-Young’s first quarter 2025 results highlight a transformational shift toward its branded aesthetic centers, which delivered a remarkable revenue increase despite overall top-line pressures. The company’s vertical integration strategy underpins expanding store density and supply chain control, setting the stage for scalable growth and improved profitability. Management’s disciplined expansion and franchise model plans signal a sustainable path forward amid evolving market dynamics.

Summary

• Branded Center Expansion Momentum: Rapid growth in aesthetic treatment services is reshaping So-Young’s revenue mix and growth drivers.
• Supply Chain Vertical Integration: Proprietary upstream capabilities are enhancing cost control and product differentiation.
• Disciplined Capital Deployment: Controlled clinic openings and franchise initiatives aim to balance growth with financial sustainability.

Business Overview

So-Young International Inc. operates as a leading aesthetic treatment platform in China, connecting consumers with online services and offline treatments. The company generates revenue through three primary segments: information, reservation services and others; aesthetic treatment services via its branded aesthetic centers; and sales of medical products and maintenance services. Its business model integrates digital platforms with physical clinics to provide standardized, cost-effective medical aesthetic solutions.

Performance Analysis

In Q1 2025, So-Young reported total revenues of RMB 297.3 million (US$41.0 million), down 6.6% year-over-year, predominantly due to a decline in subscription-based information services. The information, reservation services and others segment contracted by 34.1%, reflecting a shrinking number of subscribing medical providers. Conversely, aesthetic treatment services surged 551.4% year-over-year to RMB 98.8 million, driven by the rapid expansion of branded aesthetic centers, which now operate 23 locations across nine major Chinese cities.

Cost of revenues increased 29.1% to RMB 151.4 million, largely attributable to the new clinic network’s operational costs. Despite this, 18 centers achieved positive monthly operating cash flow by March, with 16 generating monthly profits. Operating expenses declined 20.4%, reflecting reduced sales and marketing spending and lower share-based compensation. However, net loss attributable to So-Young widened to RMB 33.1 million, underscoring ongoing investments to scale the aesthetic center business and optimize vertical integration.

• Revenue Mix Shift: Aesthetic treatment services now form a growing core, offsetting declines in legacy information services.
• Cost Structure Evolution: Increased clinic-related costs are balanced by operating efficiencies and expense discipline.
• Cash Flow Progress: Majority of aesthetic centers have reached positive cash flow, validating the business model’s scalability.

Overall, So-Young is navigating a strategic inflection, transitioning from a primarily platform-based model to a vertically integrated chain operator, with early signs of operational leverage and market traction.

Executive Commentary

Strategic Positioning

1. Accelerated Branded Aesthetic Center Rollout

So-Young is aggressively expanding its Soyang Clinic network, targeting approximately 30 new locations annually. The clinics operate in high-traffic commercial areas in first- and second-tier Chinese cities, focusing on convenience and accessibility. This "fast casual" model contrasts with traditional large flagship clinics by offering smaller centers (400 to 500 square meters) with standardized, non-surgical anti-aging treatments at affordable prices, fostering frequent customer visits and loyalty.

2. Vertical Integration of Supply Chain

The acquisition and integration of Wuhan Miracle Laser have bolstered So-Young’s upstream capabilities, enabling proprietary development and exclusive distribution of medical devices and injectable products. This vertical integration reduces reliance on costly imports, mitigates tariff risks, and enables better cost control and product quality consistency across clinics, supporting margin expansion and differentiation.

3. Digital-Physical Hybrid User Experience

Leveraging its strong internet DNA, So-Young offers a comprehensive digital platform through the Soyang Clinic app, facilitating treatment education, online reservations, and post-treatment care. This hybrid approach enhances customer engagement and convenience, differentiating So-Young from competitors reliant solely on offline channels, and strengthens private community networks to drive recurring demand.

4. Controlled Capital Deployment and Franchise Model

Management emphasizes financial discipline by pacing clinic openings to maintain sustainable cash flow, with 18 clinics already cash flow positive. The upcoming franchise model aims to accelerate geographic reach and density while reducing capital expenditure burdens, enabling scalable growth and operational leverage.

5. Strategic Response to Trade Tensions

While trade tensions pose limited direct impact on So-Young’s core aesthetic center costs, the company views tariff pressures as an opportunity to accelerate import substitution through proprietary products. The upstream supply chain’s robustness supports resilience and competitive positioning amid evolving geopolitical risks.

Key Considerations

So-Young’s Q1 results reflect a pivotal transformation in its business model, emphasizing scalable, vertically integrated clinic operations supported by proprietary supply chain assets. Investors should consider the following:

• Growth Driver Shift: The dramatic rise in aesthetic center revenues signals a new core growth engine, but legacy segments face structural decline.
• Profitability Pathway: Early positive cash flow at most clinics validates the model, yet ongoing investments and cost absorption will weigh on near-term profitability.
• Capital Efficiency: The franchise strategy and controlled clinic rollout aim to balance expansion ambitions with sustainable capital deployment.
• Competitive Differentiation: Proprietary upstream products and digital engagement create barriers to entry and enhance customer value.
• Market Positioning: The focus on non-surgical, maintenance-oriented treatments targets a high-frequency customer base, contrasting with competitors’ one-time surgical procedures.

Risks

So-Young’s transition entails execution risks related to clinic expansion pace, franchise rollout effectiveness, and integration of upstream assets. Market competition from established surgical providers and evolving consumer preferences could pressure customer acquisition and retention. Additionally, geopolitical trade tensions may affect upstream product pricing and availability, despite current mitigation efforts.

Forward Outlook

For Q2 2025, So-Young projects aesthetic treatment services revenues between RMB 120 million and RMB 140 million, representing a 337% to 410% increase year-over-year. Management plans to continue measured expansion of branded aesthetic centers and launch the franchise model to enhance network density while maintaining financial discipline. The company anticipates further margin improvement driven by product mix optimization, upstream collaboration, and operational efficiencies.

Takeaways

So-Young’s Q1 2025 results underscore a strategic pivot toward a vertically integrated, asset-light chain model anchored by proprietary products and digital engagement. The rapid growth and early profitability of aesthetic centers validate this approach, though legacy platform revenues continue to decline. The disciplined capital strategy and franchise plans aim to balance growth with sustainability, positioning So-Young to capitalize on China’s expanding medical aesthetic market.

• Emerging Growth Engine: Aesthetic centers’ explosive revenue growth and improving cash flow confirm their role as the company’s future growth backbone.
• Vertical Integration Advantage: Proprietary upstream supply chain and device development reduce costs and enhance competitive differentiation.
• Scalable Expansion Model: Controlled clinic openings and franchise initiatives mitigate capital intensity risks while enabling market penetration.

Conclusion

So-Young’s first quarter results reflect a meaningful transformation from a platform-centric business to a vertically integrated chain operator. The company’s focus on expanding branded aesthetic centers, leveraging proprietary supply chain assets, and enhancing digital engagement creates a differentiated, scalable model poised for sustainable growth. While near-term losses persist due to investments, the trajectory points toward improved profitability and market leadership in China’s medical aesthetic sector.

Industry Read-Through

So-Young’s results highlight a broader industry trend toward integrated service delivery models combining digital platforms with physical clinics. The emphasis on proprietary product development and supply chain control suggests increasing vertical integration across medical aesthetics, potentially reshaping competitive dynamics. Additionally, the focus on non-surgical, recurring treatment models reflects evolving consumer preferences favoring maintenance over one-time interventions, a shift other industry players should monitor closely.

SY Healthcare Medical Aesthetics Vertical Integration Clinic Expansion Supply Chain Digital Platform